Treatment of hypertension and metabolic syndrome: lowering blood pressure is not enough for organ protection, new approach-arterial destiffening.
about
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis.Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial.Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
P2860
Treatment of hypertension and metabolic syndrome: lowering blood pressure is not enough for organ protection, new approach-arterial destiffening.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Treatment of hypertension and ...... pproach-arterial destiffening.
@en
type
label
Treatment of hypertension and ...... pproach-arterial destiffening.
@en
prefLabel
Treatment of hypertension and ...... pproach-arterial destiffening.
@en
P2860
P1476
Treatment of hypertension and ...... pproach-arterial destiffening.
@en
P2093
Reuven Zimlichman
P2860
P2888
P356
10.1007/S11906-014-0479-Z
P577
2014-10-01T00:00:00Z
P6179
1044786278